Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.

MLA

Badheka, Apurva O., et al. “Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital Volume.” Circulation. Arrhythmia and Electrophysiology, vol. 8, no. 1, Feb. 2015, pp. 42–48. EBSCOhost, https://doi.org/10.1161/CIRCEP.114.001413.

APA

Badheka, A. O., Chothani, A., Mehta, K., Patel, N. J., Deshmukh, A., Hoosien, M., Shah, N., Singh, V., Grover, P., Savani, G. T., Panaich, S. S., Rathod, A., Patel, N., Arora, S., Bhalara, V., Coffey, J. O., O’Neill, W., Makkar, R., Grines, C. L., … Viles-Gonzalez, J. F. (2015). Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume. Circulation. Arrhythmia and Electrophysiology, 8(1), 42–48. https://doi.org/10.1161/CIRCEP.114.001413

Chicago

Badheka, Apurva O, Ankit Chothani, Kathan Mehta, Nileshkumar J Patel, Abhishek Deshmukh, Michael Hoosien, Neeraj Shah, et al. 2015. “Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital Volume.” Circulation. Arrhythmia and Electrophysiology 8 (1): 42–48. doi:10.1161/CIRCEP.114.001413.